Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-046934

Chief Executive Officer sold 12,258 shares

  • Chief Executive Officer acquired 30,992 shares (grant or award)
  • Chief Executive Officer acquired 38,394 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Davidson Michael H. · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2025-03-26 Grant or award : show line 1 in the form +30,992 364,305 D
2025-03-26 Exercise or conversion : show line 2 in the form +38,394 402,699 D
2025-03-26 Sale : show line 3 in the form −12,258 390,441 D
Open-market sales · 12,258 sh

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-26 Grant or award : show line 4 in the form Restricted Stock Unit +38,394 38,394 D
2025-03-26 Exercise or conversion : show line 5 in the form Restricted Stock Unit −38,394 0 D
Loading xslF345X05/ownership.xml…